Institute for Ophthalmic Research in Tübingen

Liquid biopsy proteomics in translational ophthalmology Julian Wolf’s research integrates multi-omics technologies and computational modeling to unravel the molecular complexity of the human eye and advance the understanding and treatment of retinal diseas...

We are absltly thrilled to welcome Julian Wolf to IOR! He uses a combination of multi-omics technologies and computational modelling to study the #retina. Save the date !
@unituebingen.bsky.social @tueneurocampus.bsky.social @uni-freiburg.de #KI #Augenheilkunde
www.eye-tuebingen.de/the-institut...

International Symposium: “Neuro-Ophthalmology Meets Vision Rehabilitation” International Interdisciplinary Symposium - 8.-9. May, 2026 in Tübingen, Germany

The symposium aims to bridge neuro-ophthalmology and vision rehabilitation. Young researchers invitation for abstracts submission of short presentations - Deadline 15. December. Places are limited !
@unituebingen.bsky.social @tueneurocampus.bsky.social

👉 www.eye-tuebingen.de?tx_news_pi1%...

Two IOR young Researchers Honored with Prestigious DOG Awards Congratulations to Angela Armento and Pietro De Angeli, who have each received prestigious prizes from the Deutsche Ophthalmologische Gesellschaft (DOG) for their groundbreaking research in retinal bi...

Congrats 👏 to Angela Armento and Pietro De Angeli, who received prestigious prizes from the @Deutsche Ophthalmologische Gesellschaft (DOG) for their research in retinal biology and innovative gene therapy!💪💪
@tueneurocampus.bsky.social @unituebingen.bsky.social
www.eye-tuebingen.de?tx_news_pi1%...

Three young scientists from the IOR Tübingen earned prestigious #RD2025 Travel Awards to present their retinal research in Prague! Congrats 💪
#RetinitisPigmentosa #AMD
@tueneurocampus.bsky.social @unituebingen.bsky.social

👉 www.eye-tuebingen.de?tx_news_pi1%...

Prof. Simon J. Clark wins the 2025 Svar Complement Excellence Award at ICW Brisbane This award highlights Simon’s outstanding contributions to complement research

Congrats to @prof-clark.bsky.social for the 2025 #Svar Complement Excellence Award at ICW Brisbane ! This Award is an annual honor for outstanding international contributions to complement science. 💪👏
@unituebingen.bsky.social @tueneurocampus.bsky.social

www.eye-tuebingen.de?tx_news_pi1%...

Congrats Simon! This is well deserved!👍👏
#AMD #ophthalmology #complement
@unituebingen.bsky.social @tueneurocampus.bsky.social

The 'Limits2Vision' International Research Training Group is offering up to 20 PhD positions. We are excited to announce that up to 20 PhD student positions (funded for up to 3.5 years) will be available in Tübingen and Paris, starting on January 1, 2026.

We are excited to announce that PhD student positions will be available in Tübingen and Paris, starting on Jan 1 2026. 👉 Deadline for application 5 October 2025!

Here further details 👉 www.eye-tuebingen.de?tx_news_pi1%...

APPLY or SHARE IT ! 🙏
@unituebingen.bsky.social @tueneurocampus.bsky.social

Tübingen and Paris Join Forces for the Future of Eye Research The binational graduate program “Limits2Vision” explores how energy metabolism operates in the healthy retina and how it is altered in retinal diseases.

🚨 New 🇩🇪🇫🇷 PhD program: #Limits2Vision by IOR Tübingen & IDV Paris🤝 to study energy metabolism in the retina—health & disease💪👏 Launching Jan 2026, funded by @dfg.de with €5M+ & FGU to train future leaders in vision research. 👁️🔬
@unituebingen.bsky.social @tueneurocampus.bsky.social
bit.ly/4eU9DLR

From Lab to Clinic: Retinal Research in Tübingen – Prof. Dr. Marius Ueffing Europe’s largest online portal for ophthalmology "Eyefox", interviewed Prof. Marius Ueffing, director of the Institute for Ophthalmic Research Tübingen

From Lab to Clinic: Retinal Research in Tübingen – Prof. Ueffing has been interviewed by Europe’s largest online portal for ophthalmology "Eyefox". German with English subtitles on YouTube.
@unituebingen.bsky.social @tueneurocampus.bsky.social

www.eye-tuebingen.de?tx_news_pi1%...

Eberhard-Dodt-Award for Sven Schumayer and Anna Nikolaidou at ISCEV 2025 Award-winning vision science: Bridging neurotech and ophthalmology at ISCEV 2025

Double win for the Applied Vision Research Group #ISCEV2025 Sven Schumayer & Anna Nikolaidou got the Eberhard-Dodt-Award for breakthroughs in #neurotech & visual electrophysiology.💪🧠👁️ #VisionScience @carlzeissstiftung.bsky.social @unituebingen.bsky.social @tueneurocampus.bsky.social
bit.ly/4kiMHqz

Molecular networks in photoreceptors – from modeling to therapeutic design by Daniele Dell´Orco

SAVE THE DATE! Dell´Orco from Verona Uni will give a talk on bottom-up computational models to unravel the complex biology of photoreceptors and its role in developing treatments for cone-rod dystrophies. #Modeling #Therapeutics
@unituebingen.bsky.social @tueneurocampus.bsky.social
bit.ly/4l2hloW

Non-invasive measuring of biopotentials of the ciliary muscle during accommodation in emmetropes This study is part of the larger interdisciplinary project "Maintaining Sharp Vision Even in Old Age"

Groundbreaking study with a non-invasive way to track ciliary muscle activity during eye focus—paves the way for smart, self-adjusting vision aids for age-related farsightedness. 👁#innovation ✨ @carlzeissstiftung.bsky.social
@unituebingen.bsky.social @tueneurocampus.bsky.social

👉 bit.ly/3FBBgfn

Eberhart Zrenner in die „Hall of Fame“ der Ophthalmologie aufgenommen

E. Zrenner has been inducted into the Hall of Fame of #Ophthalmology at #DOC2025. Pioneer of retina implant and gene therapies for vision restoration. Laudations by J-A Sahel, M Spitzer & M Ueffing honored his groundbreaking legacy.
@tueneurocampus.bsky.social

www.kaden-verlag.de/ueber-uns/na...

A landmark review of key discoveries in myopia research Short summary of 10 key lines of discovery in myopia research, as considered by the authors, and prepared on request by the chair of the International Myopia Conference (IMC) 2024, Professor Weizhong ...

For the #Myopia #IMC 2024, this review serves as historical overview and also springboard for future research, emphasising the complex interplay between genetics, visual experience and environmental factors.
@tueneurocampus.bsky.social @unituebingen.bsky.social

www.eye-tuebingen.de?tx_news_pi1%...

@carlzeissstiftung.bsky.social

Intraocular Ring Electrode Records Neuromuscular Signals of the Ciliary Muscle to Restore Accommodation in Presbyopia Recording the eye’s intent to focus: This innovation could one day help millions regain near vision lost to aging.

Researchers from iMST, Furtwangen University, and the IOR have developed an intraocular ring electrode to record ciliary muscle biopotentials—a step toward restoring natural accommodation in aging eyes.
@unituebingen.bsky.social @tueneurocampus.bsky.social
www.eye-tuebingen.de?tx_news_pi1%...

Spotlight on the 19th PRO RETINA Research Colloquium – A Showcase of Excellence in Retinal Research Strong Presence from the Institute for Ophthalmic Research, Tübingen

The annual conference by #ProRetina, brings together researchers, clinicians, and patient advocates and again demonstrates the power of collaborative research and the importance of patient-oriented science
@unituebingen.bsky.social @tueneurocampus.bsky.social

www.eye-tuebingen.de?tx_news_pi1%...

Strengthening European Ties: Institut de la Vision in Paris visits the Institute of Ophthalmic Research in Tübingen This meeting marked the first of its kind between the two institutions.

Strengthening European Ties: Institut de la Vision in Paris visits the IOR in Tübingen. This meeting was the first of its kind between the 2 internationally renowned institutes in vision and ophthalmology.
@unituebingen.bsky.social @tueneurocampus.bsky.social

www.eye-tuebingen.de?tx_news_pi1%...

New gene editing approach shows promise for specific Usher Syndrome a rare cause of hearing and vision loss Scientists and clinicians from the Center of Ophthalmology in Tübingen together with colleagues from the Department of Oncology tried a EDCas9, which emerges as a flexible and powerful editing approac...

Scientists from the Center of #Ophthalmology in Tübingen with colleagues from the Dept of #Oncology find a new gene editing approach for a specific #UsherSyndrome and for more effective future therapies!
@unituebingen.bsky.social @tueneurocampus.bsky.social

www.eye-tuebingen.de?tx_news_pi1%...

Microfabrication Aspects for the Integration of Soft Polymers in Implantable Sensors by Simon Binder

We are very glad to have as next invited speaker for our Ophthalmic Research Symposia at IOR, Simon Binder from IMTEK of the @University of @uni-freiburg.de On 13 March, let's welcome him! 👏👏👏👏
@unituebingen.bsky.social @tueneurocampus.bsky.social

Info here 👉 www.eye-tuebingen.de/default-97f5...

iPSC-derived RPE cells from donors were used to study the combined effects of genetic and environmental AMD risks. Age-related macular degeneration (AMD) is one of the main causes of blindness in the elderly population and is caused by a combination of risk factors.

#AMD is a leading cause of blindness in the elderly, driven by multiple risk factors. In this study, researchers from Tübingen employed RPE cells derived from iPSC generated from donors.
👉 www.eye-tuebingen.de?tx_news_pi1%...
@unituebingen.bsky.social @tueneurocampus.bsky.social

Dark Mode und Blaufilter: Was diese Features wirklich für unsere Augen am Bildschirm bringen - t3n – digital pioneers Einstellungen wie der Dark Mode oder auch Blaufilter sollen unsere Augen entlasten. Was sagt die aktuelle Studienlage dazu – und was nicht?

Ein weiteres lesenswertes Interview mit Prof. Schaeffel vom IOR / FIA. Der Biophysiker aus Tübingen erklärt, was die aktuelle Studienlage zum Einsatz von Dark Mode und Blaufiltern offenbart - und was nicht.

👉 t3n.de/news/dark-mo...

@unituebingen.bsky.social @tueneurocampus.bsky.social

How genetic mutations in a protein complex affect cilia, leading to ciliopathies A group of scientists from IOR in Tübingen together with colleagues from Heidelberg University, and University College London has systematically investigated 23 genetic mutations in the IFT140 gene.

Scientists from IOR in Tübingen, Heidelberg University and University College London have systematically investigated 23 mutations in the IFT140 gene to determine their effects on protein function and disease severity.
👉https://bit.ly/3EINf9W
@unituebingen.bsky.social @tueneurocampus.bsky.social

The results of this research suggest that cell’s vulnerability to oxidative stress is determined by genetic risk factors within the cells. Data support the idea that RPE cells with high genetic risk are less able to withstand oxidative stress.
@unituebingen.bsky.social @tueneurocampus.bsky.social

Myopie: Kurzsichtigkeit als wachsende Herausforderung Kurzsichtigkeit nimmt stark zu. Über die physiologischen Gründe hierfür und mögliche Behandlungsoptionen berichtete Professor Dr. Frank...

Prof. Frank Schaeffel vom IOR Tübingen war wieder als Experte gefragt! Hier ein lesenswerter Artikel über die Kurzsichtigkeit als wachsendes Problem.
#Myopie
@tueneurocampus.bsky.social @unituebingen.bsky.social

www.pharmazeutische-zeitung.de/kurzsichtigk...

Enhancing Augmented Reality: Study Explores Brightness and Resolution in Holographic Retinal Displays A collaborative Study between the "Applied Vision Research" Lab at the Institute for Ophthalmic Research, University of Tübingen, and Bosch Sensortec GmbH

A study conducted by the IOR and Bosch Sensortec GmbH, published in Applied Sciences investigates the perceived brightness and resolution of projected images directly onto retina, offering a unique AR experience without screens.
@tueneurocampus.bsky.social @unituebingen.bsky.social
bit.ly/3WEUgPd

📢 Great final talk of the semester in our Neurocolloquium on Jan 30 at 4:15pm CET: Chris Bennett from the University of Pennsylvania @upenn.bsky.social will talk about " #Brain macrophage transplantation for research and #therapy development"
👉 Sign up for Zoom: forms.gle/hJ9ZBSkzaerr...

Aging Stings: mitophagy at the crossroads of neuroinflammation by Patricia Boya

Absolutely excited to have at IOR in Tübingen Patricia Boya ! Giving a seminar on
"Aging Stings: Mitophagy at the Crossroads of Neuroinflammation"
👉Febr 6, from 2.30 to 4 p.m. at HNO Lecturehall.
Join us and let´s welcome her !
@unituebingen.bsky.social @tueneurocampus.bsky.social

bit.ly/3WxZxbA

Nitric oxide modulates contrast suppression in a subset of mouse retinal ganglion cells Nitric oxide is a type-selective neuromodulator affecting the temporal, but not the spatial response kinetics of a specific subset of mouse retinal ganglion cells.

The results in a publication of an important scientific collaboration between IOR in Tübingen and the IdV in Paris! With the first detailed analysis of the modulatory effects of nitric oxide on retinal ganglion cells.
@unituebingen.bsky.social @tueneurocampus.bsky.social

👉 doi.org/10.7554/eLif...

Institute for Ophthalmic Research in Tuebingen welcomes Dr Katrin Franke! Dr Katrin Franke joins the IOR in January 2025 to establish a new research group "Neural Computation in Vision"

Institute of Ophthalmic Research in Tübingen is happy to welcome @katrinfranke.bsky.social !
She joined us in January 2025 and wil establish a new "Neuronal Computation in Vision" Group. Congratulations !!
@unituebingen.bsky.social @tueneurocampus.bsky.social

👉 further information bit.ly/4fZR1c3